All In Biotech

Drug Trial Radar · NCT04919135

Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation

Last checked: Nov 19, 2026Latest source record: Aug 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 158 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

158

Actual

Start

Oct 19, 2021

Primary completion

Apr 20, 2023

Study completion Dec 30, 2024

Sponsor

Lead sponsor
Vinmec Research Institute of Stem Cell and Gene TechnologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 9, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is to investigate the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty treatment in Vietnam

Conditions

  • Frailty

Interventions

  • Umbilical Cord Mesenchymal Stem Cells transplantationBiological

    Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the IV route with a 3-month intervening interval

  • standard frailty treatment and supplementary medicationDrug

    Hightamine (Hankook Korus Pharm, Korea), Total calcium (Nugale Pharmaceutical, Canada), Bioflex (Ausbiomed, Australia)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse events and serious adverse eventsTime frame: up to the 9-month period following treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vinmec Research Institute of Stem Cell and Gene Technology

    Hanoi, Hanoi, Vietnam

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.